These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 33136523)

  • 1. Knowledge, attitude, and practice regarding pharmacovigilance among the general public in Western China: a cross-sectional study.
    Chen Y; Wang Y; Wang N; Xiang Y; Zhang R; Xiao J; Liu H; Feng B
    Curr Med Res Opin; 2021 Jan; 37(1):101-108. PubMed ID: 33136523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cross-sectional study: comparison of public perceptions of adverse drug reaction reporting and monitoring in eastern and western China.
    Wang N; Chen Y; Ren B; Xiang Y; Zhao N; Zhan X; Feng B
    BMC Health Serv Res; 2022 Mar; 22(1):318. PubMed ID: 35260158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria.
    Adisa R; Omitogun TI
    BMC Health Serv Res; 2019 Dec; 19(1):926. PubMed ID: 31796034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Awareness, knowledge, attitude, and practice of adverse drug reaction reporting among health workers in primary health centres participating in seasonal malaria chemoprevention campaign in Nigeria in 2022: a cross-sectional survey.
    Rotimi K; Fagbemi B; Omole G; Biambo AA; Ibinaiye T; Iwegbu A; Ogunmola O; Oguoma C; Oresanya O
    BMC Health Serv Res; 2024 Aug; 24(1):952. PubMed ID: 39164692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge, attitude and practice of General Practitioners towards adverse drug reaction reporting in South of Iran, Shiraz (Pharmacoepidemiology report).
    Peymani P; Tabrizi R; Afifi S; Namazi S; Heydari ST; Shirazi MK; Nouraei H; Sadeghi E; Lankarani KB; Maharlouei N
    Int J Risk Saf Med; 2016 Mar; 28(1):25-31. PubMed ID: 27176754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation.
    Aziz AA; Rogers S; Hassanien O; Shalaby L; Nagy M
    Per Med; 2022 Nov; 19(6):495-507. PubMed ID: 36239598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
    Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM
    Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parental reporting of adverse drug reactions in South Africa: An online survey.
    Pillay S; Mulubwa M; Viljoen M
    Afr J Prim Health Care Fam Med; 2021 Sep; 13(1):e1-e8. PubMed ID: 34636609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the factors and barriers of healthcare professionals in tertiary care hospitals toward pharmacovigilance: a multicenter study from Khyber Pakhtunkhwa, Pakistan.
    Sharif MJH; Farrukh MJ; Khan FU; Khan Q; Ahmed SS; Kousar R; Ahmad T; Abid SMA; Ashfaq M; Khan SA
    Curr Med Res Opin; 2022 Apr; 38(4):595-605. PubMed ID: 35166143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge, attitudes and practices of health care professionals towards adverse drug reaction reporting in public sector primary health care facilities in a South African district.
    Haines HM; Meyer JC; Summers RS; Godman BB
    Eur J Clin Pharmacol; 2020 Jul; 76(7):991-1001. PubMed ID: 32296857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of awareness about pharmacovigilance and adverse drug reaction monitoring in resident doctors of a tertiary care teaching hospital.
    Pimpalkhute SA; Jaiswal KM; Sontakke SD; Bajait CS; Gaikwad A
    Indian J Med Sci; 2012; 66(3-4):55-61. PubMed ID: 23603621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge, awareness, perception and reporting of experienced adverse drug reactions among outpatients in Nigeria.
    Adisa R; Adeniyi OR; Fakeye TO
    Int J Clin Pharm; 2019 Aug; 41(4):1062-1073. PubMed ID: 31140162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient Reporting of Adverse Drug Reactions (ADRs): Survey of Public Awareness and Predictors of Confidence to Report.
    Hariraj V; Aziz Z
    Ther Innov Regul Sci; 2018 Nov; 52(6):757-763. PubMed ID: 29714567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.
    Matos C; van Hunsel F; Joaquim J
    Eur J Clin Pharmacol; 2015 Jul; 71(7):883-90. PubMed ID: 26004569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing spontaneous adverse drug reaction reporting in public healthcare setting in Namibia.
    Adenuga BA; Kibuule D; Rennie TW
    Basic Clin Pharmacol Toxicol; 2020 Mar; 126(3):247-253. PubMed ID: 31520574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge, attitude and practice of physicians and nurses at the cape coast teaching hospital in the Central Region of Ghana on spontaneous adverse drug reaction reporting.
    Powell JF; Henneh IT; Ekor M
    PLoS One; 2023; 18(7):e0288100. PubMed ID: 37418384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the community pharmacist's knowledge, attitude, and practices regarding adverse drug reactions and its reporting in the United Arab Emirates: a survey-based cross-sectional study.
    Shareef J; Sridhar SB; Bhupathyraaj M; Shariff A; Thomas S
    Ther Adv Drug Saf; 2024; 15():20420986241285930. PubMed ID: 39381061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge, Attitude, and Practices regarding Pharmacovigilance and Adverse Drug Reaction reporting among Dental Students in a Teaching Hospital, Jodhpur, India: A Cross-sectional Study.
    Chhabra KG; Sharma A; Chhabra C; Reddy JJ; Deolia SG; Mittal Y
    J Contemp Dent Pract; 2017 Oct; 18(10):964-969. PubMed ID: 28989138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare personnel's experience of reporting adverse drug reactions in Baghdad city: cross-sectional study.
    Hussain SA; Abbas AN; Habeeb SA; Abd-Ali AK; Abdulrahman ZS
    Int J Clin Pharm; 2019 Oct; 41(5):1307-1313. PubMed ID: 31240554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.